Navigation Links
Insmed Partners With Bill Thomas, Former House Ways and Means Chairman, as Strategic Advisor
Date:7/17/2008

lanned clinical study design, regulatory and business strategies, strategic alternatives, plans and objectives of management and growth opportunities for existing or proposed products, constitute forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements. The risks and uncertainties include, without limitation, risks that strategic alternatives may never be consummated, product candidates may fail in the clinic or may not be successfully marketed or manufactured, we may lack financial resources to complete development of product candidates, the FDA may interpret the results of studies differently than us, competing products may be more successful, demand for new pharmaceutical products may decrease, the biopharmaceutical industry may experience negative market trends, our entrance into the follow-on biologics market may be unsuccessful, our common stock could be delisted from The NASDAQ Capital Market and other risks and challenges detailed in the Company's filings with the U.S. Securities and Exchange Commission, including the Company's Annual Report on Form 10-K for the year ended December 31, 2007. Readers are cautioned not to place undue reliance on any forward-looking statements which speak only as of the date of this release. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this release or to reflect the occurrence of unanticipated events.

Investor Relations Contact:

Brian Ritchie - FD

212-850-5683

brian.ritchie@fd.com

Matthew Duch - FD

212-850-5758

matthew.duch@fd.com

Corporate Communications Contact:

John Procter - Gibraltar Associates

202-879
'/>"/>

SOURCE Insmed Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Insmed Retains RBC Capital Markets as Strategic Financial Advisor
2. Insmed to Present at Collins Stewart Fourth Annual Growth Conference
3. Insmed to Request Hearing Before NASDAQ Panel to Review NASDAQ Staff Determination
4. Insmed Announces First Quarter 2008 Financial Results
5. Insmed to Present at CBI Follow-On Biologics Conference
6. Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulatory Pathway
7. Insmed Announces Additional Information in Compliance With NASDAQ Rules
8. Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results
9. Insmed Announces Listing Transfer from Nasdaq Global Market to Nasdaq Capital Market
10. Insmed to Host Fourth Quarter and Full-Year 2007 Conference Call
11. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Trial conducted pursuant to Special Protocol Assessment ... QUEBEC CITY, Dec. 16 /PRNewswire-FirstCall/ - AEterna ... AEZ) (the "Company"), a global biopharmaceutical company ... announced the initiation, by its partner Keryx ... Phase 3 registration clinical trial for perifosine ...
(Date:12/16/2009)... Eppendorf has initiated an,import ban ... systems for,infringement of European patent EP 1 ... and/or the quantification of a target compound". ... of the respective products into any country ... to confiscate any,violating products. , ...
(Date:12/16/2009)... hold its 23rd Annual Technical Conference & Exhibition on March 22-25, ... further impact the separation society and reach out to even more ... 2010 AFS Annual Technical Conference will be co-located with the 2010 ... ... (PRWEB) December 16, 2009 -- The American Filtration and Separations Society ...
(Date:12/15/2009)... one of three Department of Energy (DOE) bio-energy research ... protect its valuable intellectual property. , ... ... 2009 -- Surety, LLC , the leading provider ... that the Joint BioEnergy Institute (JBEI), one of three ...
Breaking Biology Technology:AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 3American Filtration and Separations Society to Hold 23nd Annual Technical Conference 4Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 3Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 4Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 5
... Inc.,(Amex: PIP ) a biodefense company developing ... the company will delay its,earnings release for the ... was previously scheduled for today, March 20, 2008. ... its earnings release and conference,call at a later ...
... March 20 On January 7,2008, Signalife received ... pursuant to which it advised that Signalife would ... threshold required for,continued listing under AMEX Rules 1003(a)(iii). ... market capitalization to less than,$50 million, which previously ...
... SCR ), a leading manufacturer and supplier of,branded ... Endu in China, today announces the appointment,of Mr. Mark ... promotion,of Baoxing Zha and Dasheng Sun as the Vice ... company also announces that Mr. Yat Ming Chu has ...
Other Biology Technology:AMEX Notifies Signalife That It Has Accepted Signalife's Plan of Compliance 2Simcere Pharmaceutical Group Announces the Appointment of New Vice President of Marketing and Two Senior Promotions 2Simcere Pharmaceutical Group Announces the Appointment of New Vice President of Marketing and Two Senior Promotions 3
(Date:12/16/2009)... its student travel award to attend the Biophysical Society,s ... San Francisco, California, February 20-24, 2010. The recipients of ... with priority given to those who will present a ... travel grant and will be recognized at a reception ... the Student Travel Award are: , , Katherine Alfieri, Haverford ...
(Date:12/16/2009)... help them get psyched up for contests, but when ... athletes gobble down before and during events, they could ... are treatments for the symptoms of an injury, not ... Indiana University focuses on musculoskeletal health and sports medicine. ... at a certain level, but pain occurs for a ...
(Date:12/16/2009)... a global provider of business process outsourcing (BPO) services, ... Awards Top 100 IT project of 2009 for its ... for iQor. ,, "We are honored to be recognized ... president and CEO of iQor. "TeQ21 is completely transforming ... faster, smarter and with the added security biometrics provides. ...
Breaking Biology News(10 mins):Biophysical Society announces winners of 2010 Student Travel Awards 2Biophysical Society announces winners of 2010 Student Travel Awards 3Biophysical Society announces winners of 2010 Student Travel Awards 4NSAIDs: Take 'em early and often when competing? Think again 2iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2SRNL to study applicability of solar cell coatings 12793 1SRNL to study applicability of solar cell coatings 12793 2In Response to SEIU Lawsuit Judge Orders State to Halt Wage Cut For California Home Care Workers 50134 1Verathon Inc Appoints Kendall Stever as Chief Financial Officer 50131 1Verathon Inc Appoints Kendall Stever as Chief Financial Officer 50131 2
... it,s likely that the salmon you had for dinner was not ... cage submerged in the open water of oceans or bays. Fish ... growing world population, now supplies, by some estimates, 30 percent of ... finfish and shellfish are now grown in farms., Intuitively, it seems ...
... The arrival of molecular genetic analysis of both ... unprecedented information about animals -- provided the researchers ... Duke University biology professor Susan Alberts. , When ... in 1987 for example, they found that avian ...
... symposium on "Defining species for threatened and endangered ... discuss the need to explicitly consider uncertainty in ... to be a contentious, but largely philosophical debate ... of organisms are identified, however, can have real, ...
Other Biology News:When fish farms are built along the coast, where does the waste go? 2Execretion analysis aids primate social studies 2Dealing with taxonomic uncertainty for threatened and endangered species 2
Caspr2 Antigen: Fusion protein amino acids 96-1265 (extracellular domain) of human Caspr2 Accession Number: NP_054860...
... Sac-Cel (Second Antibody Coated CELlulose) was ... Diagnostics of Dartford, Kent, one of the ... world. IDS acquired the product range in ... and clinical biochemists developing their own "in ...
... standard is a new tuning and calibration ... mass spectrometry. Accumix is a lyophilized ... coverage for both tuning and calibration of ... and Fourier transform mass spectrometers. Direct ...
Determin interaction of your protein with Echelons lipids...
Biology Products: